The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 115.00
Ask: 117.00
Change: -2.50 (-2.13%)
Spread: 2.00 (1.739%)
Open: 120.50
High: 120.50
Low: 115.00
Prev. Close: 117.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

31 May 2023 15:11

RNS Number : 2154B
Bakkavor Group PLC
31 May 2023
 

31 May 2023

Bakkavor Group plc

(the 'Company')

 

2023 Annual General Meeting - Poll Results

The Company's 2023 Annual General Meeting ("AGM") was held today at 10.00 am at Fitzroy Place, 5th Floor, 8 Mortimer Street, London, W1T 3JJ. All resolutions set out in the Notice of AGM dated 17 March 2023 and put to the meeting were decided on by a poll and were passed.

 

Resolutions 1 to 17 were each passed as an Ordinary Resolution (requiring a simple majority for them to be passed) and resolutions 18 to 21 were each passed as a Special Resolution (requiring at least a 75% majority for them to be passed). The results for each resolution are set out below.

 

Resolution

Votes For and Discretionary Votes

%

Votes Against

%

Total Votes Cast (Excluding Withheld)

% of ISC Voted *

Votes Withheld

1.

To receive the Annual Report and Accounts

564,145,722

 

100.00%

1,145

0.00%

564,146,867

97.36

823,400

2.

To approve the Directors' Remuneration Report

564,103,863

 

99.85%

862,259

0.15%

564,966,122

97.50

4,145

3.

To declare a final dividend on the ordinary shares of the Company for the year ended 31 December 2022 of 4.16 pence per ordinary share

 

 

 

564,969,122

 

100.00%

1,145

0.00%

564,970,267

97.51

0

4.

To re-elect Simon Burke as a Director of the Company

 

 

 

557,470,505

 

99.33%

3,744,684

0.67%

561,215,189

96.86

3,755,078

5.

To re-elect Mike Edwards as a Director of the Company

564,958,652

 

100.00%

11,615

0.00%

564,970,267

97.51

0

6.

To re-elect Ben Waldron as a Director of the Company

 

 

 

564,958,578

 

100.00%

11,689

0.00%

564,970,267

97.51

0

7.

To re-elect Sanjeevan Bala as a Director of the Company

564,958,652

 

100.00%

11,215

0.00%

564,969,867

97.51

400

8.

To re-elect Umran Beba as a Director of the Company

 

 

 

562,413,499

 

99.69%

1,733,768

0.31%

564,147,267

97.36

823,000

9.

To re-elect Jill Caseberry as a Director of the Company

563,236,899

 

99.69%

1,723,368

0.31%

564,960,267

97.50

10,000

10.

To re-elect Patrick Cook as a Director of the Company

564,958,578

100.00%

11,689

0.00%

564,970,267

97.51

0

11.

To re-elect Agust Gudmundsson as a Director of the Company

564,959,052

100.00%

11,215

0.00%

564,970,267

97.51

0

12.

To re-elect Lydur Gudmundsson as a Director of the Company

563,236,177

99.69%

1,734,090

0.31%

564,970,267

97.51

0

13.

To re-elect Denis Hennequin as a Director of the Company

563,227,530

99.69%

1,742,737

0.31%

564,970,267

97.51

0

14.

To re-elect Jane Lodge as a Director of the Company

564,958,852

100.00%

1,415

0.00%

564,960,267

97.50

10,000

15.

To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company

564,144,392

99.85%

825,875

0.15%

564,970,267

97.51

0

16.

To authorise the Audit and Risk Committee to determine the remuneration of the Auditors

564,968,308

100.00%

1,959

0.00%

564,970,267

97.51

0

17.

To authorise the Directors to allot shares

561,540,882

99.39%

3,428,836

0.61%

564,969,718

97.51

549

18.

To empower the Directors to disapply pre-emption rights

560,691,244

99.24%

4,278,074

0.76%

564,969,318

97.51

949

19.

To empower the Directors to disapply pre-emption rights for financing/refinancing particular acquisitions and other capital investments

560,700,938

99.24%

4,268,929

0.76%

564,969,867

97.51

400

20.

To authorise the Company to purchase its own shares

564,118,343

99.85%

851,924

0.15%

564,970,267

97.51

0

21.

To allow a general meeting to be called on 14 clear days' notice

564,876,291

99.98%

93,976

0.02%

564,970,267

97.51

0

 

* Based on total issued share capital as at 26 May 2023 of 579,425,585 Ordinary shares.

 

 

Votes of Independent Shareholders on the resolutions concerning the re-election of the Independent Non-executive Directors

Resolution

Votes For and Discretionary Votes

%

Votes Against

%

Total Votes Cast

% of ISC Voted **

Votes Withheld

1.

To re-elect Simon Burke as a Director of the Company

137,222,817

97.34%

3,744,684

2.66%

140,967,501

88.56

3,755,078

2.

To re-elect Sanjeevan Bala as a Director of the Company

144,710,964

99.99%

11,215

0.01%

144,722,179

90.92

400

3.

To re-elect Umran Beba as a Director of the Company

142,165,811

98.80%

1,733,768

1.20%

143,899,579

90.40

823,000

4.

To re-elect Jill Caseberry as a Director of the Company

142,989,211

98.81%

1,723,368

1.19%

144,712,579

90.91

10,000

5.

To re-elect Denis Hennequin as a Director of the Company

142,979,842

98.80%

1,742,737

1.20%

144,722,579

90.92

0

6.

To re-elect Jane Lodge as a Director of the Company

144,711,164

100.00%

1,415

0.00%

144,712,579

90.91

10,000

 

** Based on independent voting capital of 159,177,897 being total issued share capital of 579,425,585 Ordinary shares as at 26 May 2023, but 

excluding shares held by the controlling shareholders.

 

Notes:

a) The votes "For" and "Against" are expressed as a percentage of the votes received.

b) The Company's issued share capital as at 26 May 2023 is 579,425,585 ordinary shares of 2 pence each.

c) The Company's issued share capital as at 31 May 2023 is 579,425,585 ordinary shares of 2 pence each.

d) Where shareholders have appointed the Chairman of the meeting as their proxy with discretion as to voting, those votes have been cast in favour of all of the resolutions.

e) A "Vote Withheld" is not counted towards the votes cast "For" or "Against" a resolution.

f) In accordance with Listing Rule 9.2.2E, Resolutions 4, 7, 8, 9,13 and 14 (re-election of independent directors) inclusive were approved by: (a) the shareholders of the Company; and (b) the independent shareholders of the Company.

g) In accordance with Listing Rule 9.6.2, a copy of all resolutions passed other than resolutions concerning ordinary business will be submitted to the FCA via the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

-Ends-

 

Enquiries

Company Secretarial:

Annabel Tagoe-Bannerman, Group General Counsel and Company Secretary +44 (0) 20 7908 6130

 

Institutional investors and analysts:

Emily Daw, Group Financial Controller & Head of Investor Relations +44 (0) 20 7908 6114

About Bakkavor

We are the leading provider of fresh prepared food in the UK, and our presence in the US and China positions the Group well in these, high-growth markets. We leverage our consumer insight and scale to provide innovative food that offers quality, choice, convenience, and freshness. Around 18,500 colleagues operate from 44 sites across our three markets supplying a portfolio of over 2,900 products across meals, pizza & bread, salads and desserts to leading grocery retailers in the UK and US, and international food brands in China.

 

LEI number: 213800COL7AD54YU9949

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUARSROKUVOAR
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.